{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:23:05Z","timestamp":1793550185014,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113945","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:10:52Z","timestamp":1749557452000},"page":"113945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection"],"prefix":"10.1016","volume":"384","author":[{"given":"Yuxiang","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart A.","family":"Fabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin W.","family":"Pouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus P.R.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L.","family":"Trevaskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113945_bb0005","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113945_bb0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113945_bb0015","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Eleanor","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113945_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113945_bb0025","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1546298","article-title":"Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA","volume":"255","author":"Jirikowski","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.113945_bb0030","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41467-018-03190-3","article-title":"High-efficiency RNA-based reprogramming of human primary fibroblasts","volume":"9","author":"Kogut","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113945_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbrc.2010.02.150","article-title":"Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors","volume":"394","author":"Yakubov","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2025.113945_bb0040","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.scr.2016.03.008","article-title":"Generation of human induced pluripotent stem cells using non-synthetic mRNA","volume":"16","author":"Rohani","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.jconrel.2025.113945_bb0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics \u2014 developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113945_bb0050","article-title":"Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells","volume":"2","author":"Haideri","year":"2022","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.jconrel.2025.113945_bb0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.113945_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113945_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","article-title":"From influenza to COVID-19: lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases","volume":"131","author":"Pilkington","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.113945_bb0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113945_bb0090","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.113945_bb0065","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2025.113945_bb0095","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1529\/biophysj.106.083766","article-title":"Cubic phases in phosphatidylcholine-cholesterol mixtures: cholesterol as membrane \u201cfusogen\u201d","volume":"91","author":"Tenchov","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2025.113945_bb0100","series-title":"Spikevax (previously COVID-19 Vaccine Moderna)","author":"EMA","year":"2021"},{"key":"10.1016\/j.jconrel.2025.113945_bb0105","series-title":"Comirnaty","author":"EMA","year":"2020"},{"key":"10.1016\/j.jconrel.2025.113945_bb0110","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/cimb44030073","article-title":"Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 in vitro in human liver cell line","volume":"44","author":"Ald\u00e9n","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.113945_bb0115","article-title":"COVID-19 vaccine-induced myocarditis: case report with literature review","volume":"15","author":"Nassar","year":"2021","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.jconrel.2025.113945_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068665","article-title":"SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study","volume":"375","author":"Husby","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2025.113945_bb0125","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/jcm11061660","article-title":"Hypersensitivity myocarditis after COVID-19 mRNA vaccination","volume":"11","author":"Frustaci","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2025.113945_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-5173(02)00129-1","article-title":"Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating","volume":"240","author":"Levchenko","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113945_bb0135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113945_bb0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113945_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.113945_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310395","article-title":"Spleen SORT LNP generated in situ CAR T cells extend survival in a mouse model of lymphoreplete B cell lymphoma","volume":"62","author":"\u00c1lvarez-Benedicto","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2025.113945_bb0075","article-title":"Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.113945_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119291","article-title":"RNA delivery biomaterials for the treatment of genetic and rare diseases","volume":"217","author":"Zhao","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113945_bb0160","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113945_bb0165","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1021\/acsnano.3c13039","article-title":"Antiangiogenic therapeutic mRNA delivery using lung-selective polymeric nanomedicine for lung cancer treatment","volume":"18","author":"Le","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113945_bb0170","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.3390\/cimb44100341","article-title":"Lipid nanoparticles: a novel gene delivery technique for clinical application","volume":"44","author":"Mashima","year":"2022","journal-title":"CIMB"},{"key":"10.1016\/j.jconrel.2025.113945_bb0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41434-022-00370-1","article-title":"Taylor dispersion analysis to support lipid-nanoparticle formulations for mRNA vaccines","volume":"30","author":"Malburet","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2025.113945_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113945_bb0185","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acs.bioconjchem.6b00112","article-title":"NanoLuc: a small luciferase is brightening up the field of bioluminescence","volume":"27","author":"England","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.113945_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2021.112128","article-title":"Evaluation of NanoLuc substrates for bioluminescence imaging of transferred cells in mice","volume":"216","author":"Gaspar","year":"2021","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2025.113945_bb0195","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.jconrel.2025.113945_bb0200","unstructured":"Onpattro | European Medicines Agency, (n.d.). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/onpattro (accessed January 15, 2024)."},{"key":"10.1016\/j.jconrel.2025.113945_bb0205","unstructured":"Clinical Review Report: Patisiran (Onpattro) - NCBI Bookshelf, (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549757\/ (accessed January 15, 2024)."},{"key":"10.1016\/j.jconrel.2025.113945_bb0210","doi-asserted-by":"crossref","first-page":"27077","DOI":"10.1021\/acsnano.4c11652","article-title":"Blood distribution of SARS-CoV-2 lipid nanoparticle mRNA vaccine in humans","volume":"18","author":"Kent","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113945_bb0215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/apm.13294","article-title":"SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28days after COVID-19 vaccination","volume":"131","author":"Castruita","year":"2023","journal-title":"APMIS"},{"key":"10.1016\/j.jconrel.2025.113945_bb0220","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.113945_bb0225","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41591-021-01573-6","article-title":"A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus","volume":"27","author":"August","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.113945_bb0230","doi-asserted-by":"crossref","unstructured":"H. Liu, M.Z. Chen, T. Payne, C.J.H. Porter, C.W. Pouton, A.P.R. Johnston, Beyond the endosomal bottleneck: understanding the efficiency of mRNA\/LNP delivery, Adv. Funct. Mater. n\/a (n.d.) 2404510. doi: https:\/\/doi.org\/10.1002\/adfm.202404510.","DOI":"10.1002\/adfm.202404510"},{"key":"10.1016\/j.jconrel.2025.113945_bb0235","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41551-023-01150-x","article-title":"Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons","volume":"8","author":"Gu","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.113945_bb0240","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-019-12275-6","article-title":"Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells","volume":"10","author":"Maugeri","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113945_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2025.113945_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115065","article-title":"In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy","volume":"165","author":"Escalona-Rayo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.113945_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.113945_bb0260","author":"Du"},{"key":"10.1016\/j.jconrel.2025.113945_bb0265","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.omtm.2023.05.008","article-title":"Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution","volume":"29","author":"M\u00fcnter","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2025.113945_bb0270","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2025.113945_bb0275","first-page":"247","article-title":"Recent advances in lymphatic targeted drug delivery system for tumor metastasis","volume":"11","author":"Zhang","year":"2014","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jconrel.2025.113945_bb0280","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Soo Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113945_bb0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11095-022-03445-1","article-title":"Lipid microparticles show similar efficacy with lipid nanoparticles in delivering mRNA and preventing cancer","volume":"40","author":"Ji","year":"2023","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:56:54Z","timestamp":1779512214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":56,"alternative-id":["S0168365925005656"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113945","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113945"}}